J&J Announces Settlement Payments for US Probes into Risperdal Personal Injury On Monday, November 4th, Johnson & Johnson announced that they would pay $2 billion
South Carolina Toxic Tort Attorneys A toxic tort involves the exposure of individuals, often in large numbers, to harmful chemical or biological substances. When this
First Plaintiff in Series of Personal Injury Lawsuits Against DePuy All-Metal Hip Replacements Receives $8.3 Million The first bellwether trial against Johnson & Johnson and
A New Court Filing Shows that Takeda Pharmaceuticals Knew About a Possible Link Between Actos and Bladder Cancer According to a new court filing in
First Actos Bellwether Case on Trial The first bellwether case in the multidistrict litigation (MDL) against Actos, manufactured by Takeda Pharmaceuticals, began on January 27th in
Products Liability and SC Workers’ Compensation Claims: Making Injured Victims Whole Suppose you, or a family member, have been injured or damaged as a result
Jury Says Takeda and Eli Lilly Must Pay $9 Billion for Actos Bladder Cancer Japanese pharmaceutical manufacturer Takeda Pharmaceutical and their US distributor Eli Lilly
Couple Files Personal Injury Lawsuit in New Hampshire’s Federal Court Against Actos A New Hampshire couple has filed a personal injury lawsuit in federal court
This month, the FDA approved a drug called Lucentis, which can help diabetic patients with diabetic macular edema improve their eyesight. Macular edema occurs when the
Actos Injury Case in Illinois Decided in Favor of Takeda Pharmaceuticals Takeda Pharmaceuticals, the drug company behind Type 2 diabetes drug Actos, won their most